These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4405384)

  • 1. Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels.
    Spector S; Tarver J; Berkowitz B
    Pharmacol Rev; 1972 Jun; 24(2):191-202. PubMed ID: 4405384
    [No Abstract]   [Full Text] [Related]  

  • 2. Norepinephrine in blood vessels: concentration, binding, uptake and depletion.
    Berkowitz BA; Tarver JH; Spector S
    J Pharmacol Exp Ther; 1971 Apr; 177(1):119-26. PubMed ID: 5566756
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations in tyrosine hydroxylase and monoamine oxidase activity in blood vessels.
    Tarver J; Berkowitz B; Spector S
    Nat New Biol; 1971 Jun; 231(25):252-3. PubMed ID: 5284367
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of norepinephrine synthesis in blood vessels and the effects of monoamine oxidase inhibition.
    Berkowitz BA; Tarver JJ; Spector S
    J Pharmacol Exp Ther; 1974 Jul; 190(1):21-9. PubMed ID: 4152588
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine.
    Finch L; Haeusler G; Kuhn H; Thoenen H
    Br J Pharmacol; 1972 Feb; 44(2):357P-358P. PubMed ID: 4668621
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of norepinephrine synthesis in intact tissue dy drugs and during short-term adrenergic nerve stimulation.
    Weiner N; Cloutier G; Bjur R; Pfeffer RI
    Pharmacol Rev; 1972 Jun; 24(2):203-21. PubMed ID: 4405385
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive drugs and catecholamine metabolism: effects of reserpine and hydralazine on tyrosine hydroxylase activity and norepinephrine concentrations in the spontaneously hypertensive rat.
    Kohler C; Berkowitz BA; Spector S
    J Pharmacol Exp Ther; 1975 May; 193(2):443-51. PubMed ID: 238020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of catecholamine turnover by variations of enzyme levels.
    Pletscher A
    Pharmacol Rev; 1972 Jun; 24(2):225-32. PubMed ID: 4404611
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in tyrosine hydroxylase and dopa decarboxylase induced by pharmacological agents.
    Dairman W; Christenson JG; Udenfriend S
    Pharmacol Rev; 1972 Jun; 24(2):269-89. PubMed ID: 4404613
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered norepinephrine synthesis of splanchnic vessels in neurogenic hypertension.
    Dequattro V; Alexander N
    Eur J Pharmacol; 1974 May; 26(2):231-5. PubMed ID: 4152768
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy.
    Berkowitz BA; Spector S; Tarver JH
    Br J Pharmacol; 1972 Jan; 44(1):10-6. PubMed ID: 4401306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of norepinephrine contents in cardiac sympathetic neuron during high impulse activity: alterations in monoamine oxidase activity.
    Bhagat BD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():343-56. PubMed ID: 4806659
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of nitroprusside-induced hypotension on sympathetic nerve activity, tyrosine hydroxylase activity and [3H]norepinephrine uptake in rabbit vascular tissues.
    Takimoto GS; Weiner N
    J Pharmacol Exp Ther; 1981 Nov; 219(2):420-7. PubMed ID: 6116800
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamines.
    Axelrod J; Weinshilboum R
    N Engl J Med; 1972 Aug; 287(5):237-42. PubMed ID: 4402575
    [No Abstract]   [Full Text] [Related]  

  • 15. [Roles of the sympathetic nervous system and catecholamines in development of dystrophic neurological processes].
    Zavodskaya IS
    Actual Pharmacol (Paris); 1970; 23():163-74. PubMed ID: 4948984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myocardial reaction to adrenergic drugs during the early periods of development (review of the literature)].
    Viktorov AP
    Farmakol Toksikol; 1977; 40(2):239-45. PubMed ID: 15864
    [No Abstract]   [Full Text] [Related]  

  • 17. [High blood pressure, catecholamines and the sympathetic nervous system. I. Molecular-pharmacological insights].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1975 Jan; 119(4):144-53. PubMed ID: 236521
    [No Abstract]   [Full Text] [Related]  

  • 18. Catechol-O-methyltransferase and dopamine-beta-hydroxylase activity in the blood vessels of hypertensive rats.
    Trajkov T; Berkowitz BA; Spector S
    Blood Vessels; 1974; 11(3):101-9. PubMed ID: 4451724
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of drugs on uptake and release of catecholamines in the isolated left atrium of the guinea pig.
    Cervoni P; Kirpekar SM; Schwab A
    J Pharmacol Exp Ther; 1966 Feb; 151(2):196-206. PubMed ID: 5932598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.